These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 25131594)
21. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences. Lakhani VV; Ding F; Dokholyan NV PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863 [TBL] [Abstract][Full Text] [Related]
22. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease. Wetzel R Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927 [TBL] [Abstract][Full Text] [Related]
23. Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells. Lo CH; Pandey NK; Lim CK; Ding Z; Tao M; Thomas DD; Langen R; Sachs JN ACS Chem Neurosci; 2020 Aug; 11(15):2286-2295. PubMed ID: 32568514 [TBL] [Abstract][Full Text] [Related]
24. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core. Lin HK; Boatz JC; Krabbendam IE; Kodali R; Hou Z; Wetzel R; Dolga AM; Poirier MA; van der Wel PCA Nat Commun; 2017 May; 8():15462. PubMed ID: 28537272 [TBL] [Abstract][Full Text] [Related]
25. Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease. Lobato AG; Ortiz-Vega N; Zhu Y; Neupane D; Meier KK; Zhai RG Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166928. PubMed ID: 38660915 [TBL] [Abstract][Full Text] [Related]
26. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract. Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108 [TBL] [Abstract][Full Text] [Related]
27. Huntington's Disease. Finkbeiner S Cold Spring Harb Perspect Biol; 2011 Jun; 3(6):. PubMed ID: 21441583 [TBL] [Abstract][Full Text] [Related]
29. Aggregation in Huntington's disease: insights through modelling. Cajavec B; Bernard S; Herzel H Genome Inform; 2005; 16(1):262-71. PubMed ID: 16362929 [TBL] [Abstract][Full Text] [Related]
30. Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. Melkani GC; Trujillo AS; Ramos R; Bodmer R; Bernstein SI; Ocorr K PLoS Genet; 2013; 9(12):e1004024. PubMed ID: 24367279 [TBL] [Abstract][Full Text] [Related]
31. One-pot semisynthesis of exon 1 of the Huntingtin protein: new tools for elucidating the role of posttranslational modifications in the pathogenesis of Huntington's disease. Ansaloni A; Wang ZM; Jeong JS; Ruggeri FS; Dietler G; Lashuel HA Angew Chem Int Ed Engl; 2014 Feb; 53(7):1928-33. PubMed ID: 24446188 [TBL] [Abstract][Full Text] [Related]
32. Protein aggregation and neurodegeneration: clues from a yeast model of Huntington's disease. Bocharova N; Chave-Cox R; Sokolov S; Knorre D; Severin F Biochemistry (Mosc); 2009 Feb; 74(2):231-4. PubMed ID: 19267681 [TBL] [Abstract][Full Text] [Related]
33. Evidence for a recruitment and sequestration mechanism in Huntington's disease. Preisinger E; Jordan BM; Kazantsev A; Housman D Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302 [TBL] [Abstract][Full Text] [Related]
34. Huntingtin aggregation and toxicity in Huntington's disease. Bates G Lancet; 2003 May; 361(9369):1642-4. PubMed ID: 12747895 [TBL] [Abstract][Full Text] [Related]
35. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease. Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891 [TBL] [Abstract][Full Text] [Related]
36. Solid-State Nuclear Magnetic Resonance on the Static and Dynamic Domains of Huntingtin Exon-1 Fibrils. Isas JM; Langen R; Siemer AB Biochemistry; 2015 Jun; 54(25):3942-9. PubMed ID: 26020223 [TBL] [Abstract][Full Text] [Related]
37. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Muchowski PJ; Schaffar G; Sittler A; Wanker EE; Hayer-Hartl MK; Hartl FU Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7841-6. PubMed ID: 10859365 [TBL] [Abstract][Full Text] [Related]
38. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation. Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597 [TBL] [Abstract][Full Text] [Related]
39. Complex interplay between the length and composition of the huntingtin-derived peptides modulates the intracellular behavior of the N-terminal fragments of mutant huntingtin. Milewski M; Gawliński P; Bąk D; Matysiak A; Bal J Eur J Cell Biol; 2015 May; 94(5):179-89. PubMed ID: 25773959 [TBL] [Abstract][Full Text] [Related]
40. Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity. Stroedicke M; Bounab Y; Strempel N; Klockmeier K; Yigit S; Friedrich RP; Chaurasia G; Li S; Hesse F; Riechers SP; Russ J; Nicoletti C; Boeddrich A; Wiglenda T; Haenig C; Schnoegl S; Fournier D; Graham RK; Hayden MR; Sigrist S; Bates GP; Priller J; Andrade-Navarro MA; Futschik ME; Wanker EE Genome Res; 2015 May; 25(5):701-13. PubMed ID: 25908449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]